Item Type | Name |
Academic Article
|
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
|
Academic Article
|
Long-term outcome among patients with juvenile rheumatoid arthritis.
|
Academic Article
|
The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.
|
Academic Article
|
Magnetic resonance imaging in juvenile rheumatoid arthritis.
|
Academic Article
|
Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease.
|
Academic Article
|
The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients.
|
Academic Article
|
The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis.
|
Academic Article
|
Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: evidence for antigenic selection of T cells in the synovium.
|
Academic Article
|
Use of methotrexate in children.
|
Academic Article
|
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
|
Academic Article
|
Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis.
|
Academic Article
|
Social, emotional, and behavioral functioning of children with juvenile rheumatoid arthritis.
|
Academic Article
|
Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios.
|
Academic Article
|
Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis.
|
Academic Article
|
Substance use among adolescents with juvenile rheumatoid arthritis.
|
Academic Article
|
Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles.
|
Academic Article
|
A controlled longitudinal study of the social functioning of children with juvenile rheumatoid arthritis.
|
Academic Article
|
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis.
|
Academic Article
|
Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting.
|
Academic Article
|
Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
|
Academic Article
|
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
|
Academic Article
|
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire.
|
Academic Article
|
A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.
|
Academic Article
|
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting.
|
Academic Article
|
Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus.
|
Academic Article
|
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
|
Academic Article
|
Educational and occupational outcomes among young adults with juvenile idiopathic arthritis.
|
Academic Article
|
Medication choices in juvenile rheumatoid arthritis.
|
Academic Article
|
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
|
Academic Article
|
Juvenile idiopathic arthritis: management and therapeutic options.
|
Academic Article
|
Comparing parental distress, family functioning, and the role of social support for caregivers with and without a child with juvenile rheumatoid arthritis.
|
Academic Article
|
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.
|
Academic Article
|
Brief report: child-rearing practices of caregivers with and without a child with juvenile rheumatoid arthritis: perspectives of caregivers and professionals.
|
Academic Article
|
School problems and teacher responsibilities in juvenile rheumatoid arthritis.
|
Academic Article
|
Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion.
|
Academic Article
|
Arthritis in childhood.
|
Academic Article
|
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis.
|
Academic Article
|
Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis.
|
Academic Article
|
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
|
Academic Article
|
Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis.
|
Academic Article
|
Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale.
|
Academic Article
|
Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.
|
Academic Article
|
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies.
|
Academic Article
|
Emerging therapies in juvenile rheumatoid/idiopathic arthritis.
|
Academic Article
|
Differences in disease outcomes between medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis.
|
Academic Article
|
Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
|
Academic Article
|
Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993.
|
Academic Article
|
Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.
|
Academic Article
|
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
|
Academic Article
|
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
|
Academic Article
|
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.
|
Academic Article
|
Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.
|
Academic Article
|
Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis.
|
Academic Article
|
Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.
|
Academic Article
|
Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial.
|
Academic Article
|
Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyositis/dermatomyositis.
|
Academic Article
|
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.
|
Academic Article
|
The child with arthritis in the school setting.
|
Academic Article
|
Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis.
|
Academic Article
|
Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.
|
Academic Article
|
Dominant T-cell-receptor beta chain variable region V beta 14+ clones in juvenile rheumatoid arthritis.
|
Academic Article
|
Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis.
|
Academic Article
|
Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy.
|
Concept
|
Arthritis, Juvenile
|
Concept
|
Arthritis, Rheumatoid
|
Concept
|
Arthritis
|
Academic Article
|
Utility of the PedsQL rheumatology module as an outcome measure in juvenile fibromyalgia.
|
Academic Article
|
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures.
|
Academic Article
|
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
|
Academic Article
|
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
|
Academic Article
|
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease.
|
Academic Article
|
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
|
Academic Article
|
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
|
Academic Article
|
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
|
Academic Article
|
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
|
Academic Article
|
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
|